Atria Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Atria Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$586K	Sell	40,452 -3,471	-8%	-$46.8K	0.01%	1439
2026 Q1	$608K	Buy	43,923 +4,063	+10%	+$56.6K	0.01%	1336
2025 Q4	$560K	Sell	39,860 -1,085	-3%	-$15.2K	0.01%	1374
2025 Q3	$572K	Buy	40,945 +8,212	+25%	+$118K	0.01%	1348
2025 Q2	$492K	Buy	32,733 +22,052	+206%	+$315K	0.01%	1426
2025 Q1	$141K	Sell	10,681 -91	-0.8%	-$1.26K	﹤0.01%	1854
2024 Q4	$170K	Buy	+10,772	New	+$162K	﹤0.01%	1805
2024 Q3	–	Sell	-23,260	Closed	-$354K	–	2027
2024 Q2	$354K	Buy	+23,260	New	+$333K	﹤0.01%	1488

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atria Investments's RDY Position: Q2 2026 in Review

Atria Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 7.9% in Q2 2026, selling an estimated $46.8K and leaving 40,452 shares worth $586K. The position accounts for 0.01% of the portfolio, ranked #1439.

Atria Investments first reported a position in RDY in Q2 2024 and has held it in 8 quarters since. The position peaked at $608K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Atria Investments held 40,452 shares of Dr. Reddy's Laboratories worth $586K as of Q2 2026.
Atria Investments sold 3,471 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $46.8K.
Dr. Reddy's Laboratories made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1439 holding.
Atria Investments first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 8 quarters since.
Atria Investments's Dr. Reddy's Laboratories position peaked at $608K in Q1 2026.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.